EFSPI International Events

European Statistical Meeting on Non-Inferiority

Thursday 20th November 2008
Verona, Italy

This meeting was a joint venture between EFSPI, BIAS, and SSFA.

Non-inferiority trials have been around for many years, but are still controversial. Experts from industry, academia and regulatory bodies have presented and discussed a range of issues concerning these trials.
One hundred participants have attended this very fruitful meeting

  1. Vittorio Bertele’ (Institute for Pharmacological Research, Milan) Non-inferiority trials are unethical
  2. Jorgen Seldrup (Quintiles) What's inferior about a non-inferiority trial?
  3. David Brown (MHRA) Non-inferiority trials: A regulator's perspective
  4. Krishan P Singh (GlaxoSmithKline) Case studies in the design, analysis and interpretation of non-inferiority clinical trials
  5. Jon Armstrong (Astra Zeneca) Issues regarding non-inferiority within the anti-infective area
  6. Lars Endahl (Novo Nordisk) The non-inferiority margin in diabetes trials
  7. Tim Friede (University of Warwick) Sample size re-estimation in non-inferiority trials
  8. Kevin Carroll (Astra Zeneca) Non-inferiority: Issues of today and developments for tomorrow